Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 43063-913

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 43063-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063913 Label (43063913)

Label for Bupropion Hydrochloride SR 150 mg extended-release film-coated tablets. The label shows a package containing 30 tablets, NDC 43063-913-30, manufactured by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label includes dosage form, strength, lot number C22A43, and expiry date 02/2023. It also contains warnings and usage instructions.*

FDA Label Image

Image 1

Chemical structure of bupropion hydrochloride, showing its molecular arrangement including a chlorophenyl group and tert-butyl group attached to the central framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.